Clinical Trials in Chicago

Showing 181-200 of 9,860 trials

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

NCT07478679

This study will prospectively investigate the feasibility and safety of administering LDRT in patients with immunotherapy-induced inflammatory arthritis.

ArthritisArthropathy

University of Chicago20 participantsStarted Aug 2026

Chicago, Illinois, United States

COMPLETEDNA2.2 miles

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

NCT02100722

The purpose of this study is to determine whether Fractional flow reserve (FFR, (coronary pressure wire-based index for assessing the ischemic potential of a coronary lesion)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar outcomes to coronary artery bypass graft surgery (CABG).

Coronary DiseaseCoronary Stenosis

Stanford University1,500 participantsStarted Aug 2014

Palo Alto, California, United States • Stanford, California, United States • Decatur, Georgia, United States +43 more locations

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

Find Trials by Condition in Chicago

Mucopolysaccharidosis VII Disease Monitoring Program

Noninvasive Spinal Stimulation in Stroke

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Activity and Recreation in Communities for Health

Empathic Communication Skills (ECS) Training

Evolut™ EXPAND TAVR II Pivotal Trial

A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE